In this study, we investigated the level of phosphorylation of YB-1 (S102), phosphorylation of ERK1/2 (T202/Y204), and expression of EGFR in a limited number of tumor tissues from breast cancer patients, including those with TNBC. Here, EGFR is linked to breast carcinoma.